Loomis, Sayles & Company’s Novo Nordisk NVO Stock Holding History

Loomis, Sayles & Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$625M	Sell	17,017,315 -118,069	-0.7%	-$5.59M	0.84%	26
2025 Q4	$872M	Buy	17,135,384 +969,916	+6%	+$49.6M	1.05%	20
2025 Q3	$897M	Buy	16,165,468 +3,589,437	+29%	+$210M	1.07%	18
2025 Q2	$868M	Buy	12,576,031 +187,789	+2%	+$12.8M	1.09%	20
2025 Q1	$860M	Buy	12,388,242 +816,556	+7%	+$67.4M	1.24%	19
2024 Q4	$995M	Buy	11,571,686 +2,947,771	+34%	+$319M	1.26%	18
2024 Q3	$1.03B	Sell	8,623,915 -273,522	-3%	-$36.5M	1.35%	18
2024 Q2	$1.27B	Buy	8,897,437 +44,905	+0.5%	+$5.95M	1.75%	17
2024 Q1	$1.14B	Sell	8,852,532 -150,793	-2%	-$18M	1.62%	17
2023 Q4	$931M	Sell	9,003,325 -94,483	-1%	-$9.34M	1.43%	18
2023 Q3	$827M	Sell	9,097,808 -396,084	-4%	-$34.9M	1.42%	17
2023 Q2	$768M	Sell	9,493,892 -259,428	-3%	-$21.2M	1.24%	21
2023 Q1	$776M	Sell	9,753,320 -206,260	-2%	-$14.6M	1.35%	21
2022 Q4	$674M	Sell	9,959,580 -395,198	-4%	-$23.2M	1.35%	23
2022 Q3	$516M	Sell	10,354,778 -276,698	-3%	-$14.8M	1.05%	28
2022 Q2	$592M	Sell	10,631,476 -1,174,822	-10%	-$65.2M	1.1%	27
2022 Q1	$656M	Sell	11,806,298 -507,358	-4%	-$26M	0.88%	33
2021 Q4	$690M	Sell	12,313,656 -564,522	-4%	-$30.6M	0.83%	31
2021 Q3	$618M	Buy	12,878,178 +73,878	+0.6%	+$3.57M	0.76%	31
2021 Q2	$536M	Sell	12,804,300 -546,450	-4%	-$21.2M	0.65%	32
2021 Q1	$450M	Sell	13,350,750 -298,562	-2%	-$10.6M	0.58%	33
2020 Q4	$477M	Sell	13,649,312 -909,830	-6%	-$31.4M	0.63%	34
2020 Q3	$505M	Sell	14,559,142 -170,572	-1%	-$5.69M	0.74%	33
2020 Q2	$482M	Sell	14,729,714 -18,137,576	-55%	-$579M	0.77%	33
2020 Q1	$989M	Sell	32,867,290 -10,653,652	-24%	-$317M	2.04%	14
2019 Q4	$1.26B	Buy	43,520,942 +1,461,470	+3%	+$40.5M	2.14%	16
2019 Q3	$1.09B	Buy	42,059,472 +293,938	+0.7%	+$7.43M	2.09%	17
2019 Q2	$1.07B	Sell	41,765,534 -6,842	-0%	-$169K	1.99%	16
2019 Q1	$1.09B	Buy	41,772,376 +292,988	+0.7%	+$7.2M	2.15%	16
2018 Q4	$955M	Sell	41,479,388 -2,005,670	-5%	-$44.6M	2.25%	17
2018 Q3	$1.02B	Buy	43,485,058 +914,932	+2%	+$22.3M	2.01%	15
2018 Q2	$982M	Sell	42,570,126 -1,480,100	-3%	-$35.2M	1.99%	17
2018 Q1	$1.08B	Buy	44,050,226 +2,647,714	+6%	+$69.5M	2.3%	10
2017 Q4	$1.11B	Buy	41,402,512 +345,702	+0.8%	+$8.79M	2.32%	11
2017 Q3	$988M	Buy	41,056,810 +944,340	+2%	+$21.3M	2.17%	9
2017 Q2	$860M	Buy	40,112,470 +2,116,582	+6%	+$42.7M	2.03%	13
2017 Q1	$651M	Sell	37,995,888 -118,358	-0.3%	-$2.06M	1.62%	20
2016 Q4	$683M	Buy	38,114,246 +7,745,490	+26%	+$140M	1.68%	20
2016 Q3	$632M	Buy	30,368,756 +6,673,550	+28%	+$165M	1.6%	19
2016 Q2	$637M	Buy	23,695,206 +1,411,702	+6%	+$38.7M	1.73%	14
2016 Q1	$604M	Buy	22,283,504 +1,789,500	+9%	+$47.9M	1.72%	15
2015 Q4	$595M	Buy	20,494,004 +914,846	+5%	+$25.3M	1.68%	15
2015 Q3	$531M	Buy	19,579,158 +949,810	+5%	+$26.9M	1.57%	14
2015 Q2	$510M	Buy	18,629,348 +2,826,222	+18%	+$79.4M	1.4%	14
2015 Q1	$422M	Buy	15,803,126 +2,604,328	+20%	+$60M	1.18%	15
2014 Q4	$279M	Buy	13,198,798 +3,824,028	+41%	+$85.4M	0.77%	30
2014 Q3	$223M	Buy	9,374,770 +1,001,294	+12%	+$23M	0.65%	34
2014 Q2	$193M	Buy	8,373,476 +568,218	+7%	+$12.5M	0.55%	37
2014 Q1	$178M	Buy	+7,805,258	New	+$166M	0.5%	44